Pranjal Patel, MD
Pulmonary Disease · Stanford, CANPI 1972943603
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $30,509 of the $37,955 with a category attached, or 80.4%. 19 manufacturers reported payments, led by Medical Device Business Services, Inc. at 53.8% of the total. 2025 is the largest year on record at $34,079, more than ten times the $178 reported in 2019. Among pulmonary disease clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $534.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$20K
- Johnson & Johnson$12K
- Intuitive Surgical$4K
- Steris Corporation$522
- Galvanize Therapeutics, Inc$157
- Novo Nordisk$155
- plus $555 from 13 others
What the payments were for
- Consulting fees$30,50980%
- Travel & lodging$2,4616%
- Food & beverage$2,3766%
- Education$2,6097%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 3 | $20,430 |
| Johnson & Johnson(2 entities) | 13 | $12,352 |
| Intuitive Surgical | 23 | $3,783 |
| Steris Corporation | 4 | $522 |
| Galvanize Therapeutics, Inc | 1 | $157 |
| Novo Nordisk | 9 | $155 |
| Ambu Inc. | 1 | $107 |
| Pulmonx Corporation | 1 | $90 |
| Astellas Pharma US Inc | 1 | $77 |
| Boehringer Ingelheim | 4 | $63 |
| UCB, Inc. | 3 | $56 |
| ERBE USA Inc | 1 | $29 |
| Lilly USA, LLC | 1 | $25 |
| Baxter Healthcare | 1 | $24 |
| Argenx US, Inc. | 1 | $23 |
| GSK | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Novartis | 1 | $15 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,382
- MONARCH$1,530
- TRUFREEZE$433
- Monarch Platform$422
- ALIYA SYSTEM$157
How this compares
$37,955 in reported general payments places this provider in the 90th percentile of 1,261 pulmonary disease providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Stanford
- Revati ShreeniwasStanford$726K
- Deborah LevineStanford$166K
- Roham ZamanianStanford$86K
- Brian ShallerStanford$82K
- Samuel LouieSacramento$2.8M
- Shyamsunder SubramanianTracy$1.5M
- Toby MaherLos Angeles$1.3M
- Rajkumar DasguptaPasadena$930K
- Hoang leFountain Valley$814K
- Kevin FussellEncinitas$788K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.